Complicaciones neurológicas de los inhibidores de punto de control inmunológico

Suay, Guillermo; Bataller, Luis.
Rev. neurol. (Ed. impr.) ; 68(7): 301-311, 1 abr., 2019. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-183315

Documentos relacionados

  1. Checkpoint blockade toxicities: Insights into autoimmunity and treatment.
  2. Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents.
  3. Immunosurveillance in clinical cancer management.
  4. Immune-Related Oral, Otologic, and Ocular Adverse Events.
  5. Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies.
  6. Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation.
  7. [Cardiovascular toxicities associated with immune checkpoint inhibitors].
  8. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.
  9. [Endocrine consequences of immune checkpoint inhibitors].
  10. Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper.